このページの翻訳は実験的なもので、現在開発中です。お待ちしております
Austar Lifesciences バランスシートの健全性
財務の健全性 基準チェック /36
Austar Lifesciencesの総株主資本はCN¥775.5M 、総負債はCN¥430.7Mで、負債比率は55.5%となります。総資産と総負債はそれぞれCN¥2.2BとCN¥1.4Bです。
主要情報
49.5%
負債資本比率
CN¥386.27m
負債
| インタレスト・カバレッジ・レシオ | n/a |
| 現金 | CN¥139.98m |
| エクイティ | CN¥780.63m |
| 負債合計 | CN¥1.36b |
| 総資産 | CN¥2.14b |
財務の健全性に関する最新情報
Would Austar Lifesciences (HKG:6118) Be Better Off With Less Debt?
Mar 28
We Think Austar Lifesciences (HKG:6118) Has A Fair Chunk Of Debt
Sep 28Here's Why Austar Lifesciences (HKG:6118) Has A Meaningful Debt Burden
Mar 31Is Austar Lifesciences (HKG:6118) A Risky Investment?
Apr 06Austar Lifesciences (HKG:6118) Has A Pretty Healthy Balance Sheet
Oct 24Austar Lifesciences (HKG:6118) Seems To Use Debt Quite Sensibly
Mar 31Recent updates
Investors Aren't Buying Austar Lifesciences Limited's (HKG:6118) Revenues
Aug 28We Think Shareholders May Want To Consider A Review Of Austar Lifesciences Limited's (HKG:6118) CEO Compensation Package
May 24Revenues Working Against Austar Lifesciences Limited's (HKG:6118) Share Price Following 30% Dive
Apr 18Would Austar Lifesciences (HKG:6118) Be Better Off With Less Debt?
Mar 28Investors Still Aren't Entirely Convinced By Austar Lifesciences Limited's (HKG:6118) Revenues Despite 25% Price Jump
Feb 12Market Cool On Austar Lifesciences Limited's (HKG:6118) Revenues
Dec 22We Think Austar Lifesciences (HKG:6118) Has A Fair Chunk Of Debt
Sep 28Here's Why Austar Lifesciences (HKG:6118) Has A Meaningful Debt Burden
Mar 31Austar Lifesciences Limited (HKG:6118) Stock's 29% Dive Might Signal An Opportunity But It Requires Some Scrutiny
Sep 19Is Austar Lifesciences (HKG:6118) A Risky Investment?
Apr 06Austar Lifesciences (HKG:6118) Has A Pretty Healthy Balance Sheet
Oct 24With EPS Growth And More, Austar Lifesciences (HKG:6118) Is Interesting
Sep 27If You Like EPS Growth Then Check Out Austar Lifesciences (HKG:6118) Before It's Too Late
May 31Austar Lifesciences (HKG:6118) Seems To Use Debt Quite Sensibly
Mar 31Is Now The Time To Put Austar Lifesciences (HKG:6118) On Your Watchlist?
Mar 01Austar Lifesciences Limited (HKG:6118) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ?
Feb 01
Are Austar Lifesciences's (HKG:6118) Statutory Earnings A Good Guide To Its Underlying Profitability?
Jan 11Austar Lifesciences (HKG:6118) Seems To Use Debt Quite Sensibly
Dec 21Can You Imagine How Jubilant Austar Lifesciences' (HKG:6118) Shareholders Feel About Its 191% Share Price Gain?
Dec 07Here's What Austar Lifesciences Limited's (HKG:6118) Shareholder Ownership Structure Looks Like
Nov 23財務状況分析
短期負債: 6118の 短期資産 ( CN¥1.6B ) が 短期負債 ( CN¥1.2B ) を超えています。
長期負債: 6118の短期資産 ( CN¥1.6B ) が 長期負債 ( CN¥205.8M ) を上回っています。
デット・ツー・エクイティの歴史と分析
負債レベル: 6118の 純負債対資本比率 ( 33.1% ) は 満足できる 水準であると考えられます。
負債の削減: 6118の負債対資本比率は、過去 5 年間で5.4%から55.5%に増加しました。
債務返済能力: 6118の負債は 営業キャッシュフロー によって 十分にカバーされていません ( 5.6% )。
インタレストカバレッジ: 6118の負債に対する 利息支払い が EBIT によって 十分にカバーされている かどうかを判断するにはデータが不十分です。